Exchange: NYSEMkt·
News
all
press releases
Eli Lilly Stock Eyes Best Month This Year As Cholesterol, Obesity Drug Tailwinds Build
LLY's stock is still down year-to-date as AI-driven narratives have captured the bulk of investor attention and capital in 2026.
Stocktwits

Advertisement|Remove ads.